Becker's Healthcare January 11, 2022
Chief information officers at pharmaceutical companies say the metaverse could soon play a role in their business practices, The Wall Street Journal reported Jan. 10.
The Wall Street Journal interviewed three drugmakers to weigh in on this new digital frontier, an immersive, virtual reality-powered world.
Paul von Autenried, CIO of New York City-based Bristol-Myers Squibb, told The Wall Street Journal that scientists would benefit from the metaverse.
“We have scientists doing real work in laboratories with beakers and chemicals, and their ability to do their work and free up their hands is very valuable,” he said. “The metaverse for me triggers an avalanche of thoughts and technology in the space of...
Today's Sponsors
Today's Sponsor